HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.495

-0.195-3.43%

Volume:3.10M

Turnover:17.12M

Market Cap:2.15B

PE:-8.57

High:5.705

Open:5.690

Low:5.490

Close:5.690

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.50

T/O Rate:0.80%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.641

ROE:-125.57%

ROA:-44.55%

PB:6.90

PE(LYR):-8.57

PS:-160.91

Loading ...

Overview Company News Filings

PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%

Bulletin Express

Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair

Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure

PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal

MT Newswires Live

Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma

PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate

PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical

PegBio receives first HK$ 61 million royalty payment from Tenry Pharma under Visepegenatide deal

Movement Alert｜PegBio Rises 8.52% in Regular Trading, Multiple Positive Catalysts Drive Continued Rebound

PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance

Bulletin Express

PEGBIO CO-B Shares Surge Over 13% in Session as CR059 Accepted for EASD 2026 and Oral Presentation

PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026

Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment

PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot

Bulletin Express

PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference

PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership

Bulletin Express

PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026

PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process

Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff

Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02565/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.495,"timestamp":1788163726678,"preClose":5.69,"halted":0,"volume":3097850,"delay":0,"changeRate":-0.03427065026362044,"floatShares":386000000,"shares":391000000,"eps":-0.6414999608058322,"marketStatus":"Closed","change":-0.195,"latestTime":"08-31 16:08:46","open":5.69,"high":5.705,"low":5.49,"amount":17123803,"amplitude":0.037786,"askPrice":5.495,"askSize":19950,"bidPrice":5.49,"bidSize":37500,"shortable":3,"etf":0,"ttmEps":-0.9955986082621306,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":5,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.69,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.504557,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.6415,"volumeRatio":0.504557,"shares":391000000,"dividePrice":0,"high":5.705,"amplitude":0.037786,"preClose":5.69,"low":5.49,"week52Low":4.94,"pbRate":"6.90","psRate":"-160.91","week52High":77,"institutionHeld":0,"latestPrice":5.495,"committee":0.305483,"eps":-0.6414999608058322,"divideRate":0,"volume":3097850,"delay":0,"ttmEps":-0.9955986082621306,"open":5.69,"prevYearClose":69,"prevWeekClose":5.69,"prevMonthClose":5.36,"prevQuarterClose":5.33,"fiveDayClose":5.96,"twentyDayClose":5.39,"sixtyDayClose":8.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-08-28","current":-5.519293,"percent":1,"low":-87.782868,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"high":-5.766342,"avg":-43.693638,"sd":28.220965,"marketCap":2225310817},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817}],"updateTime":1788167950595},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184250474","title":"PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184250474","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184250474?lang=en_us&edition=fundamental","pubTime":"2026-06-26 12:23","pubTimestamp":1782447837,"startTime":"0","endTime":"0","summary":"On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645892645","title":"Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2645892645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645892645?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:55","pubTimestamp":1782298540,"startTime":"0","endTime":"0","summary":"PegBio appoints Yik Lam Liao as independent director, names her audit chairPegBio appointed Yik Lam Liao as an independent non-executive director, effective June 24, 2026, following shareholder voting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL4gfpMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183413158","title":"Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1183413158","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183413158?lang=en_us&edition=fundamental","pubTime":"2026-06-16 11:47","pubTimestamp":1781581627,"startTime":"0","endTime":"0","summary":"On June 16, Pegbio Biopharmaceuticals-B declined 8.23% in regular trading, trading at HK$6.48/share, with turnover of HK$35.48 million. The stock hit a fresh 52-week low amid persistent market...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641510319","title":"PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641510319","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641510319?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:31","pubTimestamp":1780893062,"startTime":"0","endTime":"0","summary":"PegBio  received the first royalty payment of HK$61 million from Shanghai Tenry Pharmaceutical over a licensing deal covering visepegenatide in China, according to a Friday filing with the Hong Kong bourse.The medicine, sold under the Paidakang brand name, is intended to treat type 2 diabetes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141451062","title":"Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1141451062","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141451062?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:22","pubTimestamp":1780885359,"startTime":"0","endTime":"0","summary":"On June 8, PegBio (Peg Bio Pharmaceuticals-B) rose 8.37% in regular trading, trading at HKD 8.4 per share, with trading volume of approximately HKD 93.36 million.On the news front, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124962385","title":"PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1124962385","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124962385?lang=en_us&edition=fundamental","pubTime":"2026-06-08 09:38","pubTimestamp":1780882703,"startTime":"0","endTime":"0","summary":"PegBio Co-B (ASX: 02565) shares have surged more than 6%. At the time of writing, the stock is up 5.38% to HKD 8.43, with a turnover of HKD 31.46 million.The significant price movement follows a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","BK4581","BK1574","BK1191","161726","399441","BK4585","02565","BK4588","XBI","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182527756","title":"PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1182527756","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182527756?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:12","pubTimestamp":1780654348,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that it has received the initial milestone payment of HK$61 million from Shanghai Tengrui Pharmaceutical Co., Ltd. This payment pertains to the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","01477","BK4588","02565","399441","BK4581","BK1574","BK1191","BK1161","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111006","title":"PegBio receives first HK$ 61 million royalty payment from Tenry Pharma under Visepegenatide deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111006","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641111006?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:06","pubTimestamp":1780653971,"startTime":"0","endTime":"0","summary":"PegBio received its first royalty payment of HK$61 million from Tenry Pharmaceutical under their Visepegenatide  commercialization collaboration.The payment signals the collaboration has moved into substantial execution in mainland China.Paidakang is a once-weekly GLP-1 receptor agonist marketed for type 2 diabetes in China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL11xp6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152329611","title":"Movement Alert｜PegBio Rises 8.52% in Regular Trading, Multiple Positive Catalysts Drive Continued Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1152329611","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152329611?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:42","pubTimestamp":1780551768,"startTime":"0","endTime":"0","summary":"On June 4, PegBio (02565.HK) rose 8.52% in regular trading, trading at HKD 8.69/share, with trading volume of HKD 142 million.On the news front, the company recently released multiple positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121378543","title":"PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1121378543","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121378543?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:05","pubTimestamp":1780477526,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145158330","title":"PEGBIO CO-B Shares Surge Over 13% in Session as CR059 Accepted for EASD 2026 and Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1145158330","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145158330?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:41","pubTimestamp":1780368088,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (02565) experienced a significant intraday surge, climbing more than 13% at one point during the morning session.At the time of writing, the stock was up 4.27%, trading at...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","161726","BK1161","399441","BK4581","XBI","02565","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142389682","title":"PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1142389682","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142389682?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:17","pubTimestamp":1780366627,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (HKEX: 02565) have surged more than 13%. At the time of writing, the stock is up 9.8% to HK$8.75, with a turnover of HK$108 million.The significant move follows a company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","399441","VXUS","BK1161","XBI","02565","BK4581","BK4588","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185585479","title":"Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1185585479","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185585479?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:05","pubTimestamp":1780365941,"startTime":"0","endTime":"0","summary":"On June 2, PegBio Pharma-B rose 10.55% in regular trading, trading at HK$8.75/share, with trading volume of HK$115 million.On the news front, the company released multiple positive catalysts in quick...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104725442","title":"PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot","url":"https://stock-news.laohu8.com/highlight/detail?id=1104725442","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104725442?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:43","pubTimestamp":1780324997,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B) has issued the formal proxy for its 2025 annual general meeting, to be convened at 10:00 a.m. (Hong Kong time) on 24 June 2026. The hybrid session will be physically...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154515574","title":"PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1154515574","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154515574?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:07","pubTimestamp":1780308430,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that its internally developed circular RNA-encoded GLP-1 analog, CR059, has had its research findings accepted for presentation at the 62nd European Association...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","02565","399441","BK4588","XBI","161726","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150034110","title":"PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1150034110","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150034110?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:05","pubTimestamp":1780308334,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B, 02565) disclosed that its next-generation GLP-1 candidate, CR059, has been accepted for an oral discussion session at the 62nd Annual Meeting of the European...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640585689","title":"PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640585689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640585689?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:02","pubTimestamp":1780308126,"startTime":"0","endTime":"0","summary":"PegBio disclosed June 1, 2026 that preclinical findings for CR059 were accepted for EASD 2026 and selected for an oral discussion session.The results were previously selected as a late-breaking abstract for the ADA Scientific Sessions; the EASD presentation is scheduled for 2026.A single dose in non-human primates supported sustained drug exposure and prolonged body-weight reduction, suggesting potential for ultra-long-acting dosing.The program uses circular RNA to drive in-body production of a GLP-1 analogue, positioning it as a differentiated approach versus peptide GLP-1 drugs.CR059 remains in R&D, with clinical development and commercialization still uncertain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL5zKjBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194812021","title":"PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process","url":"https://stock-news.laohu8.com/highlight/detail?id=1194812021","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194812021?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:20","pubTimestamp":1779963627,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) announced that its Vepetide Injection has been included in the public notice for the second batch of 2026 reference drug pre-communication supplementary drugs, as published by the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK1161","399441","161726","BK4581","BK4585","02565","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155488745","title":"Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1155488745","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155488745?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:34","pubTimestamp":1779932097,"startTime":"0","endTime":"0","summary":"PegBio Pharma's stock soared 15.53% during intraday trading on Thursday, marking a significant recovery in its share price.The sharp rise represents a technical rebound following a steep selloff in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111038713","title":"Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1111038713","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111038713?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:32","pubTimestamp":1779931937,"startTime":"0","endTime":"0","summary":"On May 28, PegBio Pharma (02565.HK) rose 10.77% in regular trading, trading at HK$10.1/share, with trading volume of HK$35.96 million.On the news front, the stock experienced a sharp technical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":120,"code":"91000000","status":"200"}]}}